公开(公告)号：US20240026407A1

公开(公告)日：2024-01-25

申请号：US18039514

申请日：2021-12-08

Applicant: GLAXOSMITHKLINE BIOLOGICALS SA

Inventor： Murray BROWN ,  Edward CHAPMAN ,  Andrew COLLIS ,  Douglas FUERST ,  Joseph HOSFORD ,  Christopher MACDERMAID ,  James MORRISON

IPC: C12P19/14 ,  C12N9/42 ,  C12N9/24 ,  A61K39/39

CPC classification number: C12P19/14 ,  C12N9/2445 ,  C12Y302/01021 ,  C12N9/2402 ,  C12Y302/0104 ,  A61K39/39 ,  A61K2039/55577

Abstract: Methods for the enzymatic modification of saponins, products made thereby, uses of said products and also to other associated aspects. The saponins may be extracts of Quillaja species, such as extracts of Quillaja saponaria Molina.

公开(公告)号：US20250163486A1

公开(公告)日：2025-05-22

申请号：US18964910

申请日：2024-12-02

Applicant: GlaxoSmithKline Biologicals SA

Inventor： Murray BROWN ,  Edward CHAPMAN ,  Andrew John COLLIS ,  Douglas E. FUERST ,  Joseph HOSFORD ,  Christopher M. MACDERMAID ,  Grégory MATHY ,  James Patrick MORRISON

IPC: C12P19/60 ,  C12N9/24 ,  C12N9/42 ,  C12P5/00 ,  C12P19/14

Abstract: Methods for the enzymatic modification of saponins produced in plant cell culture, products made thereby, uses of said products and also to other associated aspects. The saponins may be obtained from plant cell culture extracts of Quillaja species, such as extracts of Quillaja saponaria Molina.